alzheimer's disease in vitro model from Creative Biolabs's blog

Alzheimer's disease (AD) presently occupies the topmost position among the most diagnosed neurodegenerative diseases worldwide, with the number of affected people forecasted to reach 100 million by 2050. According to the latest statistics, nearly 44 million people in the world suffer from AD or related dementia, with only one in four being diagnosed with the disease. Currently, the disease has no cure available for its treatment, except for some relief from some of the symptoms. Besides its multifactorial and heterogeneous nature, AD is also progressive, i.e., the symptoms gradually worsen with the passage of years. Multiple risk factors including genetic and environmental sources have been implicated in the emergence of AD, with advancing age being identified as the most significant among them.

Creative Biolabs is an experienced custom in vitro CNS disease modeling services provider. We have been focusing on this field for more than 10 years and have developed a comprehensive technology platform. Our platform is now mature in offering various in vitro CNS disease services, including Alzheimer's disease models. With strong foundations, rich experience, and extensive expertise, we are confident in the quality of our services.

Learn more: alzheimer's disease in vitro model


Previous post     
     Blog home

The Wall

No comments
You need to sign in to comment

Post

By Creative Biolabs
Added Oct 11 '23

Tags

Rate

Your rate:
Total: (0 rates)

Archives